Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Nussenbaum

Showing results (101-110 of 137) with videos related to

Pageof 14
Sort By:
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|September 20, 2012
Clinical consensus statement: tracheostomy careRon B Mitchell, Heather M Hussey, Gavin Setzen, et al.
Cancer|August 22, 2014
Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of lifeChristopher R Spencer, Hiram A Gay, Bruce H Haughey, et al.
International Journal of Radiation Oncology, Biology, Physics|May 23, 2016
High E6 Gene Expression Predicts for Distant Metastasis and Poor Survival in Patients With HPV-Positive Oropharyngeal Squamous Cell CarcinomaShariq S Khwaja, Callie Baker, Wesley Haynes, et al.
JAMA Otolaryngology-- Head & Neck Surgery|November 2, 2018
Association of Treatment Delays With Survival for Patients With Head and Neck Cancer: A Systematic ReviewEvan M Graboyes, Anvesh R Kompelli, David M Neskey, et al.
Head & Neck|July 28, 2018
Pretreatment metabolic tumor volume as a prognostic factor in HPV-associated oropharyngeal cancer in the context of AJCC 8th edition stagingJohn M Floberg, Todd A DeWees, Re-I Chin, et al.
Oral Oncology|October 1, 2016
nab-Paclitaxel, cisplatin, and 5-fluorouracil followed by concurrent cisplatin and radiation for head and neck squamous cell carcinomaDouglas Adkins, Jessica Ley, Loren Michel, et al.
Oral Oncology|August 12, 2017
nab-Paclitaxel-based induction chemotherapy with or without cetuximab for locally advanced head and neck squamous cell carcinomaDouglas Adkins, Jessica Ley, Peter Oppelt, et al.
JAMA Otolaryngology-- Head & Neck Surgery|April 23, 2015
Treatment Outcomes for T4 Oropharyngeal Squamous Cell CarcinomaJoseph Zenga, Michael Wilson, Douglas R Adkins, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 13, 2020
Oral Intubation Attempts in Patients With a Laryngectomy: A Significant Safety ThreatMichael J Brenner, John D Cramer, Brendan A McGrath, et al.
Radiation Oncology (London, England)|January 10, 2015
Pre-radiotherapy feeding tube identifies a poor prognostic subset of postoperative p16 positive oropharyngeal carcinoma patientsVivek Verma, Jingxia Liu, Laura Eschen, et al.
Pageof 14

Showing results (101-110 of 137) with videos related to

Sort By:
Pageof 14
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|September 20, 2012
Clinical consensus statement: tracheostomy careRon B Mitchell, Heather M Hussey, Gavin Setzen, et al.
Cancer|August 22, 2014
Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of lifeChristopher R Spencer, Hiram A Gay, Bruce H Haughey, et al.
International Journal of Radiation Oncology, Biology, Physics|May 23, 2016
High E6 Gene Expression Predicts for Distant Metastasis and Poor Survival in Patients With HPV-Positive Oropharyngeal Squamous Cell CarcinomaShariq S Khwaja, Callie Baker, Wesley Haynes, et al.
JAMA Otolaryngology-- Head & Neck Surgery|November 2, 2018
Association of Treatment Delays With Survival for Patients With Head and Neck Cancer: A Systematic ReviewEvan M Graboyes, Anvesh R Kompelli, David M Neskey, et al.
Head & Neck|July 28, 2018
Pretreatment metabolic tumor volume as a prognostic factor in HPV-associated oropharyngeal cancer in the context of AJCC 8th edition stagingJohn M Floberg, Todd A DeWees, Re-I Chin, et al.
Oral Oncology|October 1, 2016
nab-Paclitaxel, cisplatin, and 5-fluorouracil followed by concurrent cisplatin and radiation for head and neck squamous cell carcinomaDouglas Adkins, Jessica Ley, Loren Michel, et al.
Oral Oncology|August 12, 2017
nab-Paclitaxel-based induction chemotherapy with or without cetuximab for locally advanced head and neck squamous cell carcinomaDouglas Adkins, Jessica Ley, Peter Oppelt, et al.
JAMA Otolaryngology-- Head & Neck Surgery|April 23, 2015
Treatment Outcomes for T4 Oropharyngeal Squamous Cell CarcinomaJoseph Zenga, Michael Wilson, Douglas R Adkins, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 13, 2020
Oral Intubation Attempts in Patients With a Laryngectomy: A Significant Safety ThreatMichael J Brenner, John D Cramer, Brendan A McGrath, et al.
Radiation Oncology (London, England)|January 10, 2015
Pre-radiotherapy feeding tube identifies a poor prognostic subset of postoperative p16 positive oropharyngeal carcinoma patientsVivek Verma, Jingxia Liu, Laura Eschen, et al.
Pageof 14